FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/12/077677 [Registered on: 05/12/2024] Trial Registered Prospectively
Last Modified On: 03/12/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Non-randomized, Active Controlled Trial 
Public Title of Study   Palonosetron vs Palonosetron And Dexamethasone In Reducing Postoperative Nausea And Vomiting After Laparoscopic Cholecystectomy 
Scientific Title of Study   Comparison Of Palonosetron Versus Palonosetron With Dexamethasone In Prevention Of Postoperative Nausea And Vomiting After laparoscopic Cholecystectomy. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Kondamuru Likhitha 
Designation  Junior Resident 
Affiliation  Dr. Pinnamaneni Siddhartha Institute of Medical Sciences and Research Foundation 
Address  Department of Anesthesiology, Dr. Pinnamaneni Siddhartha Institute of Medical Sciences and Research Foundation, Chinnaoutapalli

Krishna
ANDHRA PRADESH
521286
India 
Phone  9848724267  
Fax    
Email  likhithalovely27@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr USSA Vara Prasad 
Designation  Professor and HOD, Department of Anaesthesiology 
Affiliation  Dr. Pinnamaneni Siddhartha Institute of Medical Sciences and Research Foundation 
Address  Department of Anesthesiology, Dr. Pinnamaneni Siddhartha Institute of Medical Sciences and Research Foundation, Chinnaoutapalli

Krishna
ANDHRA PRADESH
521286
India 
Phone  9849725560  
Fax    
Email  doctorvaraprasad@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr USSA Vara Prasad 
Designation  Professor and HOD, Department of Anaesthesiology 
Affiliation  Dr. Pinnamaneni Siddhartha Institute of Medical Sciences and Research Foundation 
Address  Department of Anesthesiology, Dr. Pinnamaneni Siddhartha Institute of Medical Sciences and Research Foundation, Chinnaoutapalli


ANDHRA PRADESH
521286
India 
Phone  9849725560  
Fax    
Email  doctorvaraprasad@gmail.com  
 
Source of Monetary or Material Support  
Dr. Kondamuru Likhitha, Department of Anesthesiology, Dr. Pinnamaneni Siddhartha Institute of Medical Sciences and Research Foundation, Chinnaoutapalli, 521286, Andhra Pradesh 
 
Primary Sponsor  
Name  Dr Kondamuru Likhitha 
Address  Department of Anesthesiology, Dr. Pinnamaneni Siddhartha Institute of Medical Sciences and Research Foundation, Chinnaoutapalli, 521286, Andhra Pradesh 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Kondamaru Likhitha  Dr. Pinnamaneni Siddhartha Institute of Medical Sciences and Research Foundation  Department of Anaesthesiology, Dr. Pinnamaneni Siddhartha Institute of Medical Sciences and Research Foundation
Krishna
ANDHRA PRADESH 
9848724267

likhithalovely27@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC, Dr. Pinnamaneni Siddhartha Institute of Medical Sciences and Research Foundation  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Palonsetron and dexamethasone injection  single dose of Palonsetron and dexamethasone injection to check postoperative nausea and vomiting 
Intervention  Palonsetron injection  single dose of Palonsetron injection and check postoperative nausea and vomiting 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  American Society of Anaesthesiologist Grade 1 & 2
Age between 18 and 60 years
Patients posted for laparoscopic cholecystectomy
 
 
ExclusionCriteria 
Details  not willing to give consent
age less than 18 yrs and more than 60yrs
history of allergy to palonsetron and dexamethasone
electrolyte abnormalities
patient with drug history of SSRI and drugs which cause QT prolongation. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Not Applicable 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Primary objectives of this study is to assess the efficacy of monotherapy(palonosetron) vs combination therapy(palonosetron – dexamethasone) in preventing postoperative nausea and vomiting  2 years 
 
Secondary Outcome  
Outcome  TimePoints 
Secondary objective is to study the number of rescue doses of antiemetics needed.  2 years 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   17/12/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

●         Post-operative nausea and vomiting (PONV) is the second most common complaint in post-operative period after pain.

●           Although nausea and vomiting in post-operative period was reported to occur in 20%–30% of all laparoscopic surgeries and especially laparoscopic cholecystectomy significantly increases the incidence of PONV to as high as 50%.

●          Palonosetron is a second-generation 5-HT3 receptor antagonist having greater receptor binding affinity with a half-life of 40 h

●          Most of the literature and recent guidelines favours the use of dexamethasone and palonosetron, some studies differ in opinion.

  In this context, we hypothesised that the combination of palonosetron and dexamethasone will be better antiemetic for PONV prophylaxis than the individual medication and this study was planned to accept or reject that hypothesis. 
Close